Literature DB >> 24290036

To the Editor: Molecular epidemiology of toxigenic Clostridium difficile isolates in Korea.

S Y Cho1, Y Nam1, Y S Soh2, T S Park1, H J Lee1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24290036      PMCID: PMC9151209          DOI: 10.1017/S0950268813003051

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


× No keyword cloud information.
  5 in total

1.  Detection of Clostridium difficile as a routine diagnosis: comparison of real-time PCR and enzyme immunoassay.

Authors:  Sun Young Cho; You-sun Nam; Min Jin Kim; Jin-Tae Suh; Hee Joo Lee; Heejung Kim
Journal:  Am J Clin Pathol       Date:  2012-03       Impact factor: 2.493

2.  Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.

Authors:  Heejung Kim; Seok Hoon Jeong; Kyoung Ho Roh; Seong Geun Hong; Jong Wan Kim; Myung-Geun Shin; Mi-Na Kim; Hee Bong Shin; Young Uh; Hyukmin Lee; Kyungwon Lee
Journal:  Korean J Lab Med       Date:  2010-10

3.  Morbidity and mortality associated with Clostridium difficile ribotype 078: a case-case study.

Authors:  L Patterson; M H Wilcox; W N Fawley; N Q Verlander; L Geoghegan; B C Patel; T Wyatt; B Smyth
Journal:  J Hosp Infect       Date:  2012-09-01       Impact factor: 3.926

4.  Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.

Authors:  J Kim; J O Kang; H Kim; M-R Seo; T Y Choi; H Pai; E J Kuijper; I Sanders; W Fawley
Journal:  Clin Microbiol Infect       Date:  2012-06-19       Impact factor: 8.067

5.  Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.

Authors:  Y S Kim; D S Han; Y H Kim; W H Kim; J S Kim; H S Kim; H S Kim; Y S Park; H J Song; S J Shin; S K Yang; B D Ye; C S Eun; K M Lee; S H Lee; B I Jang; S A Jung; J H Cheon; C H Choi; K C Huh
Journal:  Epidemiol Infect       Date:  2012-04-12       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.